Access cutting-edge mogad treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access mogad specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mogad treatment provided free
The main objective of this study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of an adjudicated MOGAD relapse in the double-blind (DB) treatment period. Participants who experience an adjudicated relapse or complete the DB period can enter open-label extension (OLE) period. After the primary clinical cutoff date (CCOD), additional adolescent participants may be enrolled directly into the OLE period.
Sponsor: Hoffmann-La Roche
Check if you qualify for this mogad clinical trial in Washington Dc, DC
If you're searching for mogad treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mogad specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.